Get a Group Membership for your Organization. Free Trial
Pricing
Free TrialLogin

Thyroid Cancer: A (Hopefully) Practical Approach to Ultrasound of the Post-Operative Neck, Dr. Deborah Baumgarten, (08/02/21)

HIDE
PrevNext

0:00

All right. Hello and welcome to Noon Conferences hosted by MRI online in

0:05

response to the changes happening around the world right now in the shutting

0:08

down of in person events. We've decided to provide free Noon Conferences

0:11

to all radiologists worldwide. Today we are joined by Dr. Deborah Baumgarten.

0:15

She is an abdominal radiologist focusing on ultrasound CT of benign and

0:19

malignant GU and GI conditions. She is active in service and education,

0:25

mentoring trainees and junior faculty, active in radiology societies and

0:28

reviews for multiple journals. Reminder that there will be a Q&A session

0:31

at the end of this lecture. So please use that Q&A feature to

0:34

ask all of your questions and we'll get to as many as we

0:36

can before our time is up. That being said, thanks for joining us

0:39

today, Dr. Baumgarten. I'll let you take it from here.

0:42

Hi, good afternoon. And hopefully as soon as I hit share,

0:47

you're seeing the right screen here. Thank you for that introduction.

0:50

I've also got the Q&A box open, so if there are questions that

0:54

come up during the talk and I happen to see them,

0:57

I will try to answer questions as we go along as well.

1:01

So I'm going to be speaking to you about ultrasound to monitor thyroid

1:04

cancer patients for recurrence after surgery. I have no disclosures.

1:11

So my learning objectives are that by the end of the session,

1:15

you should be able to differentiate normal reactive and malignant nodes,

1:20

at least malignant nodes from thyroid cancer. Keep in mind that the features

1:23

that I'm sharing with you today are pretty specific for thyroid cancer.

1:28

So other head and neck malignancies may look a little bit different.

1:32

I want you to be familiar with the patterns of node spread so

1:34

that you know where to look for recurrences.

1:38

I want you to be able to recognize the normal postoperative thyroid fossa

1:42

in contrast to a patient who's had a local recurrence.

1:46

And then we'll talk really briefly about the 2015 American Thyroid Association

1:51

or ATA guidelines as they relate to the postoperative patient so that we

1:56

can apply them in a thoughtful and consistent manner.

2:00

So what does the ATA recommend in postoperative patients?

2:06

So they say that the thyroid bed, the central and lateral cervical nodal

2:10

compartments should be imaged by ultrasound every 6 12 months.

2:14

And you should really spend a lot of time looking

2:19

where anybody has had a previous malignant node. So if you know preoperatively

2:24

that they had nodes at level 6 and say level 2, those are

2:28

the areas that you tend to have recurrences again.

2:32

The risk of nodal recurrence increases with the number of nodes that are

2:37

involved at the initial surgery. So the larger the number involved,

2:40

the more likely they are to have a nodal recurrence.

2:43

If there's extra nodal extension at the time of that initial surgery,

2:47

if they have macroscopic, described macroscopic involvement, not microscopic

2:52

in a node, and if you have a patient who has an elevated

2:55

thyroglobulin, those are things that should make you look really hard for

3:01

a recurrence. And if it's going to change management, knowing whether a

3:07

node is positive or negative, then ultrasound guided fine needle aspiration

3:11

is recommended by the ATA for any suspicious nodes that are greater than

3:15

about 8 10 millimeters. Smaller than that and they get harder to get

3:19

a good sample. Although we have been asked to and have biopsy nodes

3:23

as small as 5 millimeters if it's really going to change management.

3:27

If they're just going to treat somebody with radioactive iodine or chemotherapy,

3:31

or if they have widespread metastatic disease otherwise, and it's not going

3:35

to make a difference whether a particular node is positive or negative,

3:38

we don't need to do this. So where do we look for metastatic

3:43

lymph nodes? So this is a schematic of the neck and we've exposed

3:48

the musculature here, which is easier to see on CT than it is

3:52

on ultrasound, but we can divide the neck into various compartments.

3:57

So we have the central compartment, which is level 6, which includes the

4:00

thyroid fossa and central lymph nodes that may be a little bit below

4:05

the thyroid fossa. The levels 2, 3, and 4 are along the jugular

4:11

chain and it's hard to see the landmarks that differentiate levels 2, 3,

4:15

and 4. So I just think about it as dividing the neck into

4:19

thirds with level 2 at the top, level 3 in the middle,

4:22

and level 4 as you come down toward the clavicle.

4:27

Level 1, submandibular, and level 5, which is more posterior, we tend to

4:32

ignore those when we're doing our postoperative checks, unless the patient

4:37

complains of something palpable or unless you know they've had a recurrence

4:41

there before, because these areas tend to be involved less frequently.

4:49

So what features do we look for to differentiate normal from abnormal lymph

4:53

nodes? So normal or benign nodes, that's a start there.

4:59

They're generally oval or elongated in shape. And you can see here,

5:02

this is an elongated node. When we turn on it, it's not round.

5:06

It's about 12 x 4 x 5 millimeters.

5:10

The only exception to this nice oval shape is in the submandibular and

5:14

submental spaces, level 1. But again, we're not going to routinely look

5:18

there unless the patient's complaining about something. Those nodes tend

5:22

to be a little more lobulated and a little more bizarre looking.

5:26

The cortex is relatively hypoechoic to the surrounding soft tissues.

5:30

We have an echogenic hilum. And if there is flow that we can

5:35

detect, it's going to be vascularity that comes in at the hilum. Here's

5:42

another benign node, kind of an oval, again, a hypoechoic cortex. We have

5:48

hilar flow. We don't actually see the hilum all that well.

5:52

The flow is going to imply where that hilum is.

5:57

And another benign node here. We have sort of a nice trilaminar appearance

6:01

here where we have that hypoechoic cortex and then the hilum here.

6:05

And again, it has that oval shape and flow that is coming in

6:11

and branching from the hilum. Reactive nodes are a brand or kind of

6:18

benign node that are just a little bit in a hyperdrive there.

6:22

They may be a little bit larger than regular benign nodes, but they

6:25

remain oval or elongated. And again, that's except in the level 1, but

6:31

again, we're not routinely looking there. The cortex remains hypoechoic.

6:36

The hilum remains echogenic. And they tend to have increased flow.

6:42

And now sometimes you have to be careful if your gain settings are

6:45

really high, you may get a lot of flow in a node that

6:48

may not be real. So if your gain settings are appropriate,

6:51

they should have increased flow compared to a normal node. Now,

6:55

if you see a patient who has a lot of nodes that look

6:59

benign...

Report

Faculty

Deborah Baumgarten, MD, MPH, FACR, FSAR

Professor of Radiology

Mayo Clinic Jacksonville

Tags

Neuroradiology

© 2024 MRI Online. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy